Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 7
Submit an article Journal homepage
3,144
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials

Joon Hyung Kima GSK, Rockville, MD, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6014-3543View further author information
ORCID Icon,
John Diaz-Decaroa GSK, Rockville, MD, USAORCID Iconhttps://orcid.org/0000-0001-6487-2113View further author information
ORCID Icon,
Ning Jiangb GSK, Beijing, ChinaView further author information
,
Shinn-Jang Hwangc Department of Family Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan;d National Yang Ming University School of Medicine, Taipei City, TaiwanORCID Iconhttps://orcid.org/0000-0003-3217-6193View further author information
ORCID Icon,
Eun Ju Chooe Department of Infectious Diseases, SoonChunhyang University Bucheon Hospital, Bucheon-si, Republic of KoreaView further author information
,
Maribel Cof GSK, Wavre, BelgiumView further author information
,
Andrew Hastiea GSK, Rockville, MD, USAView further author information
,
David Shu Cheong Huig Department of Medicine and Therapeutics, The Chinese University of Hong Kong Prince of Wales Hospital, Sha Tin, Hong KongView further author information
,
Junya Irimajirih Department of Dermatology, Shonan Kamakura General Hospital, Kanagawa, JapanView further author information
,
Jacob Leei Department of Internal Medicine, Division of Infectious Diseases, Kangnam Sacred Heart Hospital, Seoul, Republic of KoreaView further author information
,
Edward Man-Fuk Leungj Department of Medicine and Geriatrics, Division of Geriatric Medicine and Rehabilitation, United Christian Hospital, Kwun Tong, Hong KongView further author information
,
Haiwen Tangk GSK, Shanghai, ChinaView further author information
,
Tomomi Tsurul Medical CO.LTA PS Clinic, Fukuoka, JapanView further author information
,
Philip Watsonm GSK, Middlesex, UKView further author information
,
Zhenhua Wub GSK, Beijing, ChinaView further author information
,
Chong-Jen Yun Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan;o National Taiwan University Hospital Biomedical Park Branch Hospital, Zhubei City, Hsinchu County, TaiwanView further author information
,
Yanfei Yuanb GSK, Beijing, ChinaORCID Iconhttps://orcid.org/0000-0002-5366-2599View further author information
ORCID Icon,
Toufik Zahaff GSK, Wavre, BelgiumORCID Iconhttps://orcid.org/0000-0002-2049-5210View further author information
ORCID Icon,
Anthony L. Cunninghamp The Westmead Institute for Medical Research, Westmead, Australia;q University of Sydney, Sydney, AustraliaORCID Iconhttps://orcid.org/0000-0002-6744-5667View further author information
ORCID Icon &
Anne Schuinda GSK, Rockville, MD, USAORCID Iconhttps://orcid.org/0000-0003-3544-0682View further author information
ORCID Icon show all
Pages 2050-2057 | Received 17 Sep 2020, Accepted 25 Nov 2020, Published online: 19 Feb 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Paul K. S. Chan, Martin C. S. Wong, Macy Chan, Karen Ching, Nikolaos Giannelos & Cheryl Ng. (2023) Public health impact of herpes zoster vaccination on older adults in Hong Kong. Human Vaccines & Immunotherapeutics 19:1.
Read now

Articles from other publishers (3)

Desmond Curran, T. Mark Doherty, Nicolas Lecrenier & Thomas Breuer. (2023) Healthy ageing: Herpes zoster infection and the role of zoster vaccination. npj Vaccines 8:1.
Crossref
Yuwei Sun, Kaitlyn Jackson, Cyril A. Dalmon, Brett L. Shapiro, Sixiang Nie, Carmen Wong, Benjamin F. Arnold, Travis C. Porco & Nisha R. Acharya. (2021) Effectiveness of the recombinant zoster vaccine among Kaiser Permanente Hawaii enrollees aged 50 and older: A retrospective cohort study. Vaccine 39:29, pages 3974-3982.
Crossref
Joseph Fiore, Maribel Miranda Co-van der Mee, Andrés Maldonado, Lisa Glasser & Phil Watson. (2021) Safety and reactogenicity of the adjuvanted recombinant zoster vaccine: experience from clinical trials and post-marketing surveillance. Therapeutic Advances in Vaccines and Immunotherapy 9, pages 251513552110574.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.